BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38125755)

  • 1. A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer.
    Gupta S; Silveira DA; Piedade GPS; Ostrowski MP; Mombach JCM; Hashimoto RF
    Noncoding RNA Res; 2024 Mar; 9(1):185-193. PubMed ID: 38125755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-145-5p Targets Sp1 in Non-Small Cell Lung Cancer Cells and Links to BMI1 Induced Pemetrexed Resistance and Epithelial-Mesenchymal Transition.
    Chang WW; Wang BY; Chen SH; Chien PJ; Sheu GT; Lin CH
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer.
    Cui Y; Li G; Zhang X; Dai F; Zhang R
    Oncol Lett; 2018 Oct; 16(4):4821-4828. PubMed ID: 30250547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer.
    Zhang J; Wang M; Wang J; Wang W
    Cell Death Dis; 2022 Jan; 13(1):65. PubMed ID: 35046387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis.
    Chen W; Tan X; Yang Q; Fang Z; Xu Y
    Cell Signal; 2022 Jun; 94():110326. PubMed ID: 35367362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALAT1 Promotes Cell Tumorigenicity Through Regulating miR-515-5p/EEF2 Axis in Non-Small Cell Lung Cancer.
    Rong F; Liu L; Zou C; Zeng J; Xu Y
    Cancer Manag Res; 2020; 12():7691-7701. PubMed ID: 32943920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis.
    Tuo Z; Liang L; Zhou R
    J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
    Wang D; Zhang S; Zhao M; Chen F
    Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
    Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness.
    Shen HT; Chien PJ; Chen SH; Sheu GT; Jan MS; Wang BY; Chang WW
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death.
    Gupta S; Silveira DA; Mombach JCM; Hashimoto RF
    Noncoding RNA Res; 2023 Dec; 8(4):605-614. PubMed ID: 37767112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
    Gupta S; Hashimoto RF
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.
    Wu X; Tan Y; Tang X
    Biomed Res Int; 2022; 2022():8093949. PubMed ID: 35601153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis.
    Wang Y; Wang X; Han L; Hu D
    Cancer Manag Res; 2020; 12():9999-10010. PubMed ID: 33116856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 Aggravates the Progression of Non-Small Cell Lung Cancer by Stimulating the Expression of COMMD8 via Targeting miR-613.
    Wang S; Wang T; Liu D; Kong H
    Cancer Manag Res; 2020; 12():10735-10747. PubMed ID: 33149680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via Down-Regulating miR-202 Expression.
    Tiansheng G; Junming H; Xiaoyun W; Peixi C; Shaoshan D; Qianping C
    Cell J; 2020 Oct; 22(3):375-385. PubMed ID: 31863664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.